AU2003294259B2 - Synergistic combinations with analgesic properties comprising N-acylated 4-hydroxyphenylamine derivatives - Google Patents

Synergistic combinations with analgesic properties comprising N-acylated 4-hydroxyphenylamine derivatives Download PDF

Info

Publication number
AU2003294259B2
AU2003294259B2 AU2003294259A AU2003294259A AU2003294259B2 AU 2003294259 B2 AU2003294259 B2 AU 2003294259B2 AU 2003294259 A AU2003294259 A AU 2003294259A AU 2003294259 A AU2003294259 A AU 2003294259A AU 2003294259 B2 AU2003294259 B2 AU 2003294259B2
Authority
AU
Australia
Prior art keywords
analgesic
composition according
opioid analgesic
opioid
scp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003294259A
Other languages
English (en)
Other versions
AU2003294259A1 (en
Inventor
Nicolas G. Bazan
Julio Alvarez Builla
Dennis Paul
Carlos Sunkel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Louisiana State University
Original Assignee
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Louisiana State University filed Critical Louisiana State University
Publication of AU2003294259A1 publication Critical patent/AU2003294259A1/en
Assigned to The Board of Supervisors of Louisiana State Univeristy and Agricultural and Mechanical College reassignment The Board of Supervisors of Louisiana State Univeristy and Agricultural and Mechanical College Request for Assignment Assignors: LSU MEDICAL CENTER FOUNDATION
Application granted granted Critical
Publication of AU2003294259B2 publication Critical patent/AU2003294259B2/en
Assigned to BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE reassignment BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE Alteration of Name(s) of Applicant(s) under S113 Assignors: THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AU2003294259A 2002-11-12 2003-11-12 Synergistic combinations with analgesic properties comprising N-acylated 4-hydroxyphenylamine derivatives Ceased AU2003294259B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/292,105 US6864271B2 (en) 2002-11-12 2002-11-12 Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
US10/292,105 2002-11-12
PCT/US2003/036039 WO2004043460A1 (en) 2002-11-12 2003-11-12 Synergistic combinations with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives

Publications (2)

Publication Number Publication Date
AU2003294259A1 AU2003294259A1 (en) 2004-06-03
AU2003294259B2 true AU2003294259B2 (en) 2008-12-18

Family

ID=32229373

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294259A Ceased AU2003294259B2 (en) 2002-11-12 2003-11-12 Synergistic combinations with analgesic properties comprising N-acylated 4-hydroxyphenylamine derivatives

Country Status (9)

Country Link
US (1) US6864271B2 (enExample)
EP (2) EP2074996A1 (enExample)
JP (1) JP2006508137A (enExample)
AT (1) ATE429913T1 (enExample)
AU (1) AU2003294259B2 (enExample)
CA (1) CA2509252A1 (enExample)
DE (1) DE60327466D1 (enExample)
ES (1) ES2325369T3 (enExample)
WO (1) WO2004043460A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2435722T3 (es) * 1997-09-04 2013-12-23 Demerx, Inc. Noribogaína en el tratamiento del dolor y de la adicción a drogas
US7064140B2 (en) * 2002-11-12 2006-06-20 Carlos Sunkel Synergistic combinations including N-acylated 4-Hydroxyphenylamine derivatives and caffeine
US8026266B2 (en) * 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
JP6049615B2 (ja) 2010-07-23 2016-12-21 デマークス・インコーポレイテッドＤｅｍｅｒｘ，Ｉｎｃ． ノリボガイン組成物
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
EP2788003A4 (en) 2011-12-09 2015-05-27 Demerx Inc PHOSPHATESTER OF NORIBOGAIN
CA2858721C (en) 2011-12-11 2021-03-16 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
WO2015195673A2 (en) 2014-06-18 2015-12-23 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US554636A (en) * 1896-02-11 Exercising-iviachine
US562110A (en) * 1896-06-16 Relasting-machine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4599342A (en) 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US6127352A (en) * 1988-02-01 2000-10-03 Uribe; Jose R. Pharmaceutical compositions with analgesics containing codeine
HU219332B (hu) * 1991-09-06 2001-03-28 Mcneilab Inc Transz-(+)-2-[(dimetil-amino)-metil]-1-(3-metoxi-fenil)-ciklohexanolt és acetaminofent tartalmazó szinergetikus gyógyszerkészítmények
US5554636A (en) * 1995-04-21 1996-09-10 Lsu Medical Center Foundation N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
US5840731A (en) 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
WO1998032434A1 (en) 1997-01-29 1998-07-30 Chong Kun Dang Corp. New analgesic composition
FR2770131A1 (fr) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US6143278A (en) * 1998-02-23 2000-11-07 Elkhoury; George F. Topical application of opioid analgesic drugs such as morphine
GB9804885D0 (en) * 1998-03-06 1998-04-29 Merck Sharp & Dohme Therapeutic combination
JPWO2001078681A1 (ja) * 2000-04-17 2004-01-08 山之内製薬株式会社 薬物動態学的な薬物相互作用を回避する薬物送達システム及びその方法
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US554636A (en) * 1896-02-11 Exercising-iviachine
US562110A (en) * 1896-06-16 Relasting-machine

Also Published As

Publication number Publication date
ES2325369T3 (es) 2009-09-02
EP1572204A1 (en) 2005-09-14
AU2003294259A1 (en) 2004-06-03
EP1572204B1 (en) 2009-04-29
JP2006508137A (ja) 2006-03-09
ATE429913T1 (de) 2009-05-15
DE60327466D1 (de) 2009-06-10
US20040092541A1 (en) 2004-05-13
US6864271B2 (en) 2005-03-08
WO2004043460A1 (en) 2004-05-27
EP2074996A1 (en) 2009-07-01
CA2509252A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
US6864271B2 (en) Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
US4599342A (en) Pharmaceutical products providing enhanced analgesia
US6054451A (en) Analgesic composition and method for alleviating pain
US5919826A (en) Method of alleviating pain
CA2323805C (en) Analgesic combination comprising nmda receptor antagonists and narcotic analgesics
JP2006508137A5 (enExample)
CA2381797C (en) Composition comprising a tramadol material and an anticonvulsant drug
US6451857B1 (en) Analgesic compositions comprising anti-epileptic compounds and methods of using same
JP2000508341A (ja) 片頭痛の治療法及び薬効の強化組成物
IE58314B1 (en) Pharmaceutical products providing enhanced analgasia
US6538008B1 (en) Combination of a selective NMDA NR2B antagonist and an opioid analgesic
CA2544648A1 (en) Analgesic compounds, their synthesis and pharmaceutical compositions containing them
AU4998799A (en) Topical compositions comprising an opioid analgesic and an nmda antagonist
AU2025279727A1 (en) Combinations of opioids and N-acylethanolamines
AU2004247138B2 (en) Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives and caffeine
WO2004026291A1 (en) Oral formulations of ibuprofen and tramadol, methods and preparation thereof
EP1797883A2 (en) Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVER

Free format text: FORMER APPLICANT(S): LSU MEDICAL CENTER FOUNDATION

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired